SEC Form 4 · accession 0000899243-16-030259
Novan, Inc. · NOVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Sep 26, 2016
Accepted (ET)
Sep 28, 2016 · 6:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467154
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 26, 2016 | C | 1,823,485 | $0.00 | A | 1,823,485 | I | See Footnote |
| Common StockF1 | Sep 26, 2016 | P | 800,000 | $11.00 | A | 2,623,485 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mezzanine A StockF1,F2 | — | Sep 26, 2016 | C | 1,823,485 | D | — | — | Common Stock | 1,823,485 | 0 | I |
Explanation of responses
- F1Malin Life Sciences Holdings Limited, the record holder of the shares, is a wholly owned subsidiary of Malin Corporation plc. Malin Corporation plc may be deemed to beneficially own the shares and may be deemed to share voting and dispositive power over these shares.
- F2The preferred stock automatically converted into common stock on a 1-to-1 basis upon the closing of the Issuer's initial public offering.